» Authors » Ahmed M Mohammed

Ahmed M Mohammed

Explore the profile of Ahmed M Mohammed including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 161
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Osman S, Yassin A, Yassin T, Mohammed A, Abdelsalam A, Mahdi W, et al.
AAPS PharmSciTech . 2025 Jan; 26(1):37. PMID: 39820832
The present work focuses on the production of sildenafil co-evaporates loaded emulgels as topical dosage forms for the treatment of premature ejaculation and erectile dysfunction. Topical administration of sildenafil citrate...
2.
Hamadalneel Y, Mohammed A, Ahmed S, Yousef A, Mohammed M, Alamin M
BMC Infect Dis . 2024 Sep; 24(1):947. PMID: 39256663
Purpose: To evaluate the diagnosis and management of bacterial meningitis in adult Sudanese patients in accordance with the Infectious Diseases Society of America (IDSA) guidelines for bacterial meningitis management. Patients...
3.
Elshaer M, Osman S, Mohammed A, Zayed G
Pharm Dev Technol . 2024 Jul; 29(7):691-702. PMID: 39045751
Hesperidin (HSP) is a natural flavonoid glycoside with very low aqueous solubility and a slow dissolution rate, limiting its effectiveness. This study aims to address these issues by creating co-crystals...
4.
Osman S, Yassin T, Abdelzaher A, Ahmed F, Mohammed A, Abdellatif A, et al.
AAPS PharmSciTech . 2024 Jan; 25(1):18. PMID: 38263347
Due to tenoxicam (TX)'s poor aqueous solubility (0.072 mg/ml), it is poorly absorbable in the GIT, and the long-term oral administration of TX may cause severe GIT disturbances. Topical administration...
5.
Amin H, Amin M, Osman S, Mohammed A, Zayed G
Int J Biol Macromol . 2023 Jul; 246:125638. PMID: 37392910
Due to its poor solubility and systemic side effects, gefitinib (Gef) has limited application in treatment of lung cancer. In this study, we used design of experiment (DOE) tools to...
6.
Abdellatif A, Ahmed F, Mohammed A, Alsharidah M, Al-Subaiyel A, Samman W, et al.
Int J Nanomedicine . 2023 Jun; 18:3247-3281. PMID: 37337575
The real problem in pharmaceutical preparation is drugs' poor aqueous solubility, low permeability through biological membranes, and short biological t. Conventional drug delivery systems are not able to overcome these...
7.
Almawash S, Mohammed A, El Hamd M, Osman S
Gels . 2023 Apr; 9(4). PMID: 37102938
Breast cancer is the second most common cancer in women worldwide. Long-term treatment with conventional chemotherapy may result in severe systemic side effects. Therefore, the localized delivery of chemotherapy helps...
8.
Dagnaw W, Mohammed A
ACS Omega . 2023 Mar; 8(9):8488-8496. PMID: 36910957
Catalytic hydrogenation is one of the most important reaction types commonly used in chemistry and chemical industry. Recently, there has been significant interest in developing a metal-free hydrogenation catalyst to...
9.
Shafique M, Rehman M, Kamal Z, Alzhrani R, Alshehri S, Alamri A, et al.
Front Pharmacol . 2023 Feb; 14:1025013. PMID: 36825154
The purpose of this study was to assess the parameters of doxorubicin (DOX) loaded lipid polymer hybrid nanoparticles (LPHNs) formulation development, and then the bioavailability of DOX were determined in...
10.
Osman S, Yassin T, Mohammed A, Alfayomy A, Abdellatif A, Mahdi W, et al.
AAPS PharmSciTech . 2023 Jan; 24(1):44. PMID: 36703092
Tenoxicam (TX) is a non-steroidal anti-inflammatory agent that can be used to control pain in various ophthalmic lesions like cataracts, refractive surgery, and corneal abrasion. TX has a very slightly...